Search Clinical Trials

589,087 trials

NCT07645066
Not Yet RecruitingNot Applicable
Posterosuperior Bundle Pacing for Prevention of Atrial Fibrillation in Patients With Sinus Node DysfunctionShanghai Tong Ren Hospital
NCT07643961
Not Yet RecruitingNot Applicable
Outpatient Versus Inpatient Management of Mild Acute PancreatitisCenter for Traumatology and Major Burns, Ben Arous
NCT07646535
Not Yet RecruitingPhase 2
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary AldosteronismShenzhen Salubris Pharmaceuticals Co., Ltd.
NCT07646067
Not Yet RecruitingNot Applicable
Closed Loop Glucose Control in a Simulated ICU SettingEmory University
NCT07644754
Not Yet RecruitingNot Applicable
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory MetastasesLudwig-Maximilians - University of Munich
NCT07645508
Active Not Recruiting
Comparison of Conventional, Patient-Specific, and Augmented Reality Navigation in Reverse Total Shoulder ArthroplastyKrankenhaus Barmherzige Schwestern Linz
NCT07644611
Not Yet Recruiting
Sleep, Mental Fatigue, and Performance in StudentsL.U.de.S. Sagl
NCT07645391
Recruiting
Targeted Early Detection Program in Men at High Genetic Risk for Prostate CancerNational Cancer Institute (NCI)
NCT07644325
RecruitingNot Applicable
Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament BiopsyClinique Saint Jean, France
NCT07646249
Not Yet Recruiting
VENtilation Modalities During Transport of PostoperatIve CRITically Ill Patients to the ICUAzienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
NCT07645469
Not Yet RecruitingPhase 1
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid LeukemiaFred Hutchinson Cancer Center
NCT07645248
Not Yet RecruitingPhase 3
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)GlaxoSmithKline
NCT07645105
Completed
Body Weight Reduction and Metabolic/Biochemical Parameters in Overweight or ObesityMedical University of Silesia
NCT07646054
Not Yet RecruitingNot Applicable
Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers23andMe, Inc.
NCT07645118
Not Yet RecruitingPhase 2
Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal CancerDr. Te Vuong
NCT07645144
Enrolling By InvitationNot Applicable
FES-assisted Gait Training for Incomplete Spinal Cord InjuryStichting Reade
NCT07644897
RecruitingPhase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen University
NCT07646028
Not Yet RecruitingPhase 1
R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)Rise Therapeutics LLC
NCT07644312
Not Yet RecruitingPhase 2
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPGNationwide Children's Hospital
NCT07643987
Completed
Diagnosis of Gestational Diabetes Based on a 50-gram Glucose ChallengeMethodist Health System